Related Experiment Video

Updated: Jun 10, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

Validation of a dystonia screening questionnaire: testing in a cohort of mixed neurological disorders

Dorinda Snik, Britt Sofie Hoffland, Maria Aguirregomozcorta

    Parkinsonism & Related Disorders
    |August 6, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Screening People on Standing Balance with Romberg Testing and Walking Balance with Tandem Walking
    06:28

    Screening People on Standing Balance with Romberg Testing and Walking Balance with Tandem Walking

    Published on: September 1, 2023

    Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
    07:26

    Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

    Published on: September 26, 2019

    Related Experiment Videos

    Last Updated: Jun 10, 2026

    Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
    10:41

    Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

    Published on: September 12, 2020

    Screening People on Standing Balance with Romberg Testing and Walking Balance with Tandem Walking
    06:28

    Screening People on Standing Balance with Romberg Testing and Walking Balance with Tandem Walking

    Published on: September 1, 2023

    Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
    07:26

    Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

    Published on: September 26, 2019

    Related Concept Videos

    Alterations in Muscle Tone ll01:12

    Alterations in Muscle Tone ll

    Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...

    Articles linked to this work by shared authors, journal, and citation graph.

    Convergent validity, responsiveness, and meaningful within-subject change of the PROM-Ataxia in spinocerebellar ataxias.

    Journal of neurology·2026

    [The rise of genetic therapies: urgent moral and societal questions].

    Nederlands tijdschrift voor geneeskunde·2026

    Association of rare apolipoprotein E ε4 homozygosity with an earlier age at onset in spinocerebellar ataxia type 3.

    Human molecular genetics·2026

    Remote Assessment of Ataxia Severity in SCA3 Across Multiple Centers and Time Points.

    Annals of clinical and translational neurology·2026

    Peripheral and autonomic nervous system involvement in spinocerebellar ataxia type 3: unveiling an invisible burden.

    Journal of neurology·2026

    The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI Cohort.

    CNS drugs·2025

    Subthalamic nucleus beta oscillations and sleep disorders in Parkinson's disease: A new perspective on deep brain stimulation regulation mechanisms and circuits.

    Parkinsonism & related disorders·2026

    MRI-derived choroid plexus volume and longitudinal cognitive decline in Parkinson's disease.

    Parkinsonism & related disorders·2026

    Hope or hype: novel disease-modifying treatments for Huntington disease.

    Parkinsonism & related disorders·2026

    Disentangling amantadine response variability in levodopa related dyskinesias: Role of clinical and genetic factors.

    Parkinsonism & related disorders·2026

    Plantar-predominant sudomotor dysfunction in multiple system atrophy: a Sudoscan and 123I-MIBG myocardial scintigraphy study.

    Parkinsonism & related disorders·2026

    Short-term efficacy and safety of tavapadon for Parkinson's disease: An exploratory systematic review and meta-analysis of randomized clinical trials.

    Parkinsonism & related disorders·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us